<DOC>
	<DOCNO>NCT02293681</DOCNO>
	<brief_summary>The purpose observational ( study follow participant forward time ) study compare functional improvement hip joint use Harris hip score 2 treatment group ( infliximab conventional therapy ) Week 30 ankylose spondylitis ( autoimmune disease cause chronic inflammation tendon end ligament attachment point ) participant hip involvement .</brief_summary>
	<brief_title>An Observational Study Infliximab Participants Suffering From Ankylosing Spondylitis With Hip Involvement</brief_title>
	<detailed_description>This multi-center ( 1 hospital medical school team work medical research study ) , observational study compare effectiveness infliximab conventional therapy ankylose spondylitis participant hip joint involvement . The study conduct 3 part : 14-day screening , 30-week first follow-up ( Follow-up 1 ) , additional 22-week follow-up ( Follow-up 2 ) Week 52 . Participants assign two group base current treatment receiving : cohort 1 participant receive infliximab without combination disease modify drug ( DMARDs-such Sulfasalazine , Methotrexate Thalidomide ) and/or non-steroidal anti-inflammatory drug ( NSAIDs ) cohort 2 receiving DMARDs and/or NSAIDs treatment pain observe . Participants primarily assess change harris hip score . Participants ' safety monitor throughout study .</detailed_description>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<mesh_term>Sulfasalazine</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>Diagnosed ankylose spondylitis ( AS ) ( accord modify New York Criteria AS ) least 3 month prior Day 1 Followup I phase symptom active disease atScreening/Baseline Hip pain duration hip symptom le 2 year Harris hip score less ( &lt; ) 70 Hip involvement proven Magnetic resonance imaging ( MRI ) Being treat infliximab conventional therapy 2 week 6 month Participant history hip joint disability consider irreversible Participant history hip joint replacement Participant history treatment biologics infliximab less 6 month prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Spondylitis , Ankylosing</keyword>
	<keyword>Infliximab</keyword>
	<keyword>Non-steroidal anti-inflammatory drug</keyword>
	<keyword>Disease-modifying anti-rheumatic drug</keyword>
</DOC>